| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |